This Netherlands population-based study followed causes of death in patients with NSCLC diagnosed 1989-2008, including more than 72,000 patients. For those with localized disease, lung cancer was the cause of death in 80-85% for years 0-3, 60-75% for years 4-6, and remained the cause of death for more than 30% thereafter. After 6 years CAD and COPD
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cancer
March 16, 2015
March 16, 2015
The authors describe results of initial bronchoscopy therapy (IBT) for endobronchial carcinoids aimed at relieving obstruction, accurate subtyping, and potentially complete eradication. After a minimum follow-up of 5 years, 42% of patients were spared surgical therapy, having had no evidence of local or distant recurrence (42/83 with typical histolo
March 16, 2015
With the increase in solitary pulmonary nodule identification anticipated with increased CT screening, the authors devised a novel method of bronchoscopically biopsying nodules not adjacent to airways. Using endoscopic instruments, a transparenchymal tunnel was created between a bronchial entry point to the nodule, and biopsies were obtained. The p
March 13, 2015
Worldwide, lung cancer is a leading cause of death. Minimally invasive resection of small pulmonary nodules is an opportunity and a challenge at the same time. The smaller the nodule, the better the long-term outlook for the patient, but the more difficult the resection. An efficient solution can be found in intra-operative 3D imaging and guided navigation.
March 12, 2015
Samples from tissue microarrays of 552 NSCLC patients were analyzed to measure the levels of 3 different tumor-infiltrating lymphocytes (TILs): CD3, CD8, and CD20. An elevated level of CD3 or CD8 was associated with longer survival.
March 10, 2015
A review of the National Cancer Data Base was undertaken to determine the impact of postoperative radiation therapy on survival for patients with pathologic stage IIIA NSCLC in the setting of adjuvant chemotherapy.
March 9, 2015
This video demonstrates how to create a subxiphoid port for use in wedge resection, lobectomy, or segmentectomy for lung cancer.
February 21, 2015
A survey involving the general public identified opinions regarding lung cancer. Most felt it was related to smoking and lifestyle, was a serious cancer, and involved major treatments. The participants underestimated cure rates for early stage disease (52% survival) and overestimated overall survival (32% survival).
February 21, 2015
Indications for postoperative radiation therapy (PORT) for resected lung cancer are unclear. This study evaluated outcomes from the National Cancer Data Base 2004-2006, including 2115 patients resected with pathologic N2 NSCLC, of whom 918 (43%) received PORT. PORT was associated with better median survival (42 vs 38 mos, p=0.048) and was associat
February 21, 2015
SEER outcomes from 1973-2010 were evaluated, including a total of over 947,000 pts, of whom only 441 had atypical carcinoid tumors of the lung. 69% were women and 87% were white. 20% had stage IV disease at diagnosis. 78% of the patients underwent resection. 3-year survival was 85% for N0, 69% for N1-2, and 26% for stage IV.